Publications by authors named "Nicolas Moosmann"

Claim this Profile
P
Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial.
Alexander Stein, Eray Goekkurt, Salah-Eddin Al-Batran, Nicolas Moosmann, Thomas J Ettrich

Nat Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial.
Rainer Fietkau, Michael Ghadimi, Robert Grützmann, Uwe A Wittel, Lutz Jacobasch, Nicolas Moosmann

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114).
Kathrin Heinrich, Volker Heinemann, Sebastian Stintzing, Lothar Müller, Thomas J Ettrich, Nicolas Moosmann

Oncol Res Treat· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial.
Beate Rau, Hauke Lang, Alfred Koenigsrainer, Ines Gockel, Horst-Guenter Rau, Nicolas Moosmann

J Clin Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321).
Joseph Tintelnot, Alexander Stein, Salah-Eddin Al-Batran, Thomas Ettrich, Thorsten Götze, Nicolas Moosmann

Front Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases - The PARLIM trial (AIO KRK 0314).
Dominik Paul Modest, Meinolf Karthaus, Stefan Kasper, Nicolas Moosmann, Verena Keitel

Eur J Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy.
Annabel H S Alig, Volker Heinemann, Michael Geissler, Ludwig Fischer von Weikersthal, Thomas Decker, Nicolas Moosmann

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amphiregulin Expression Is a Predictive Biomarker for Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials.
Arndt Stahler, Sebastian Stintzing, Dominik P Modest, Ingrid Ricard, Clemens Giessen-Jung, Nicolas Moosmann

Clin Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"" caudate lobe and inferior vena cava resection following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal and liver metastasis of colorectal cancer.
Patricia Sánchez-Velázquez, Nicolas Moosmann, Ingolf Töpel, Pompiliu Piso

World J Gastroenterol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study Group.
Sebastian Stintzing, Christine Kapaun, Rüdiger Paul Laubender, Andreas Jung, Jens Neumann, Nicolas Moosmann

Int J Cancer· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis for prognostic factors of 60-day mortality: evaluation of an irinotecan-based phase III trial performed in the first-line treatment of metastatic colorectal cancer.
Clemens Giessen, Sebastian Stintzing, Ruediger Paul Laubender, Donna Pauler Ankerst, Christoph Schulz, Nicolas Moosmann

Clin Colorectal Cancer· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Colon cancer: adjuvant chemotherapy and aftercare].
Volker Heinemann, Clemens Giessen, Dominik Modest, Nicolas Moosmann, Sebastian Stintzing

MMW Fortschr Med· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial.
Clemens Giessen, Ludwig Fischer von Weikersthal, Axel Hinke, Sebastian Stintzing, Frank Kullmann, Nicolas Moosmann

BMC Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group.
Nicolas Moosmann, Ludwig Fischer von Weikersthal, Ursula Vehling-Kaiser, Martina Stauch, Holger G Hass

J Clin Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The treatment of colorectal carcinoma with monoclonal antibodies: the importance of KRAS mutation analysis and EGFR status.
Sebastian Stintzing, Volker Heinemann, Nicolas Moosmann, Wolfgang Hiddemann, Andreas Jung

Dtsch Arztebl Int· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tool for scoring of acneiform skin eruptions induced by EGF receptor inhibition.
Andreas Wollenberg, Nicolas Moosmann, Elisabeth Klein, Kerstin Katzer

Exp Dermatol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer.
Stefan Boeck, Ralf Wilkowski, Christiane J Bruns, Rolf D Issels, Christoph Schulz, Nicolas Moosmann

Oncology· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancer.
Nicolas Moosmann, Volker Heinemann

Expert Rev Anticancer Ther· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer.
Nicolas Moosmann, Volker Heinemann

Clin Colorectal Cancer· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective second-line treatment with cetuximab and bevacizumab in a patient with hepatic metastases of colorectal cancer and hyperbilirubinemia.
Nicolas Moosmann, Dorit Laessig, Henrik Jakob Michaely, Christoph Schulz, Volker Heinemann

Onkologie· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Neoadjuvant and adjuvant therapies for solid tumours].
Volker Heinemann, Nicolas Moosmann

MMW Fortschr Med· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Importance of neoadjuvant chemotherapy in gastrointestinal tumors. A new standard?].
Nicolas Moosmann, Stefan Boeck, Volker Heinemann

Med Klin (Munich)· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab in the treatment of metastatic colorectal cancer.
Nicolas Moosmann, Volker Heinemann

Expert Opin Biol Ther· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential role of extra- and intracellular superoxide anions for nitric oxide-mediated apoptosis induction.
Mareike Steinmann, Nicolas Moosmann, Mareike Schimmel, Christina Gerhardus, Georg Bauer

In Vivo· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis